The fifth annual post-graduate symposium of the doctoral program in molecular medicine by Huhtala, Tuulia et al.
Publications of the University of Eastern Finland
Reports and Studies in Health Sciences
isbn 978-952-61-0386-0
Publications of the University of Eastern Finland
Reports and Studies in Health Sciences
The Doctoral Program in Molecular 
Medicine combines systematic docto-
ral education of the highest quality 
to the best research expertise in mo-
lecular medicine at the A. I. Virtanen 
Institute for Molecular Sciences and 
Department of Medicine in the Fa-
culty of Health Sciences in the Uni-
versity of Eastern Finland.
This book compiles the abstracts of 
the 5th Annual Post-Graduate Sym-
posium of the Doctoral Program in 
Molecular Medicine to be held in 
Katinkulta, Vuokatti, on March 15 – 
16, 2011.
R
EPO
RTS A
N
D
 STU
D
IES | 0
05  | T
u
u
lia H
u
h
ta
la et a
l. | T
h
e F
ifth
 A
n
n
u
al P
ost-G
radu
ate S
ym
p
osiu
m
 of th
e D
octoral P
rogram
... 
Tuulia Huhtala et al.
The Fifth Annual Post-
Graduate Symposium of the
Doctoral Program in
Molecular Medicine
Winter School 2011 Abstracts
Tuulia Huhtala et al.
The Fifth Annual Post-Graduate
Symposium of the Doctoral Program
in Molecular Medicine
Winter School 2011 Abstracts
  
 
 
 
TUULIA HUHTALA, ANNE JÄÄSKELÄINEN, LAURI LEHTO, TEEMU 
NATUNEN, JANNE RUOTSALAINEN, PÄIVI SUTINEN, RIIKKA PELLINEN 
The Fifth Annual Post-
Graduate Symposium of the 
Doctoral Program in 
Molecular Medicine 
Winter School 2011 
Abstracts 
Publications of the University of Eastern Finland 
Reports & Studies in Health Sciences 
 5 
 
University of Eastern Finland 
Faculty of Health Sciences 
A.I. Virtanen Institute 
Kuopio 
2011 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kopijyvä Oy 
Kuopio, 2011 
Editors: Prof. Veli-Matti Kosma 
Prof. Hannele Turunen 
Prof. Olli Gröhn 
Distribution: 
Eastern Finland University Library / Sales of publications 
P.O. Box 1627, FI-70211 Kuopio, Finland 
tel. +358 207 87 2001 
http://www.uef.fi/kirjasto 
 
ISBN: 978-952-61-0386-0 
ISBN: 978-952-61-0387-7 (PDF) 
ISSN: 1798-5722 
ISSN: 1798-5730 (PDF) 
ISSNL: 1798-5722 
 The Fifth Annual Post-Graduate Symposium of the Doctoral Program in Molecu lar 
Medicine, Winter School 2011, Abstracts. Publications of the University of Eastern 
Finland . Reports and  Stud ies in Health Sciences 5. 2011. 48 p . 
ISBN: 978-952-61-0386-0 
ISSN: 1798-5722 
 
 
 
ABSTRACT 
 
The Doctoral Program in Molecular Medicine combines systematic d octoral 
education of the highest quality to the best research expertise in molecular 
medicine at the A. I. Virtanen Institu te for Molecular Sciences and  Department of 
Medicine in the Faculty of Health Sciences in the University of Eastern Finland . 
The doctoral students of the school work as active researchers in the participating 
research groups whose scientific activities belong to six research programs: 
Card iovascular Diseases, Type 2 Diabetes and  Card iovascular Diseases, Type 2 
Diabetes and  Obesity, Neurodegenerative Diseases, Stem Cell Research, and  
Inflammatory States.  
 
This book compiles the abstracts of the 5th Annual Post-Graduate Symposium of 
the Doctoral Program in Molecular Medicine to be held  in Katinkulta, Vuokatti, on 
March 15 – 16, 2011. 
 
 
 
 
Universal Decimal Classification: 577 
National Library of Medicine Classification: W 20.5, QU 4, QZ 52, WG 120, WL 
140, WL 359, WL 385, WK 810, QY 58, WN 185 
Medical Subject Headings: Biomedical Research; Congresses; Molecu lar  Biology; 
Gene Therapy; Genetic Vectors; Gene Transfer Techniques; Glioma/ therapy; 
Vascu lar Endothelial Growth Factor ; Collagen; Diabetes Mellitus, Type 2; Insu lin; 
Sirtuins; Card iovascular Diseases; Epilepsy; Neurodegenerative Diseases/ therapy; 
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Disease Models, Animal; 
Magnetic Resonance Imaging; Microarray Analysis; Signal Transduction. 
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DOCTORAL PROGRAM IN MOLECULAR MEDICINE 
WINTER SCHOOL 2011 
MARCH 15 – 16, KATINKULTA VUOKATTI 
 
PROGRAM 
 
Tuesday, March 15 
 
7:00  Departure from Bioteknia 1 (Neulaniementie 2) 
9:45 – 10:15 Coffee, Poster set up  
10:15 – 10:25 Opening of the Symposium Seppo Ylä-Hert tuala 
 
10:25 – 11:45 ORAL SESSION I 
Chairs: Merja Jaronen and Sara Paulo 
 
10:25 – 10:45 Brain d isorders: from mechanisms to treatments Gundars 
Goldsteins  
10:45 – 11:00 IVIG alleviates cognitive d eficits after global cerebral ischemia in 
C57/ Bl6 mice and  provides time and  dose dependent 
neuroprotection Riikka Heikkinen 
11:00 – 11:15 Minocycline inhibits formation of insoluble TAU aggregates in 
vitro Taisia Rolova 
11:15 – 11:30 Contribution of monocytic cells derived  from hematopoietic stem 
cells of bone marrow in the clearance of Aβ of Alzheimer’s d isease 
Ekaterina Savchenko  
11:30 – 11:45 Stem cell derived  human neural progenitors restore gait 
impairments in a mouse model of cerebral stroke Kaisa 
Savolainen 
 
11:45 – 12:45  LUNCH & EXHIBITION  
 
12:45 – 14:10 ORAL SESSION II 
Chairs: Emilia Kansanen and Heini Belt  
 
12:45 – 13:00 A naturally occurring dominant-negative splice variant regulates 
the responsiveness of Galphaq-regulated  RhoGTPase activators 
Lili Li 
13:00 – 13:15 Androgen- and  glucocorticoid -induced  activation of FKBP51 locus 
through long-range interactions Ville Paakinaho 
13:15 – 13:30 Effects of SUMO (small ubiqu itin -related  mod ifier) modification 
on androgen receptor Päiv i Sut inen 
13:30 – 13:45 The effect of SIRT1 on antioxidant response element mediated  
gene regulation Hanna Leinonen 
13:45 – 14:00 The absence of macrophage NRF2 promotes atherogenesis in early 
but not in late stages of atherosclerosis Anna-Kaisa Ruotsalainen 
14:00 – 14:10 Sigma Life Sciences – Prod uct update Marko Santala  
 
14:10 – 15:10 COFFEE, POSTER SESSION & EXHIBITION  
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15:10 – 16:45 ORAL SESSION III 
Chairs: Sofya Ziyatdinova and Lakshman Puli 
 
15:10 – 15: 30 DPMM PhD student feedback summary Riikka Pellinen 
15:30 – 15:45 Urokinase-type plasminogen activator receptor modulates 
epileptogenesis in mouse model of temporal lobe ep ilepsy  Xavier 
Ekolle Ndode-Ekane 
15:45 – 16:00 Role of amyloidogenic APP processing in epilep togenesis Diana 
Miszczuk 
16:00 – 16:15 Loss of GABAergic neurons in the rat dentate gyrus during 
epileptogenesis depend s on the type of ep ileptogenic insu lt Noora 
Huusko 
16:15 – 16:30 Migraine mediator CGRP up -regulates pacemaker channels in 
meningeal nerves and  in isolated  trigeminal neurons: a novel 
mechanism of head ache? Azat  Abdullin 
16:30 – 16:45 The role of serine 275 in shap ing of the bind ing pocket of ATP-
gated  P2X3 receptor Natalia Pet renko  
 
16:45 – 20:00 CHECK IN, OUTDOOR ACTIVITIES 
 
20:00 DINNER 
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DOCTORAL PROGRAM IN MOLECULAR MEDICINE 
WINTER SCHOOL 2011 
MARCH 15 – 16, KATINKULTA VUOKATTI 
 
PROGRAM 
 
Wednesday, March 16 
 
7:00 – 8:20 Breakfast 
 
8:25 – 9:45 ORAL SESSION IV 
Chairs: Jussi Paananen and Sanna-Kaisa Häkkinen 
 
8:25 – 8:45 In the light of nutrigenetics: you are what you  eat? Tiina 
Lappalainen 
8:45 – 9:00 Microfibrillar associated  protein 5 (MFAP5) is linked  with 
markers of obesity-related  extracellular matrix remodeling and  
inflammation Maija Vait t inen 
9:00 – 9:15 TCF7L2 sp licing is regulated  by weight loss and  d iffers between 
fat depots in humans Dorota Kaminska 
9:15 – 9:30 Association of ind ices of liver and  ad ipocyte insulin resistance 
with 19 confirmed  susceptibility loci for type 2 d iabetes in 6,733 
non-d iabetic Finnish men Jagadish Vangipurapu 
9:30 – 9:45 Pred iction of microRNA targets in C. Elegans using a self 
organizing map Liisa Heikkinen 
 
9:45 – 10:30 BREAK, POSTER SESSION AND EXHIBITION  
 
10:30 – 11:45 ORAL SESSION V 
Chairs: Janne Ruotsalainen and Joanna Huttunen 
 
10:30 – 10:45 Calcification detection in vivo and  ex vivo in injured  rat brain 
using SWIFT Lauri Lehto 
10:45 – 11:00 Simultaneous fMRI and  local field  potential measurements of 
pentylenetetrazol induced  epileptic seizures in traumatic brain 
injury rats Ant t i Airaksinen 
11:00 – 11:15 Rotating frame spin lattice relaxation time mapping and  cine MRI 
of myocard ial infarcted  mice in vivo at 9.4 T Haja-Sherief N. 
Musthafa 
11:15 – 11:30 Interferon-beta sensitivity of tumour cells correlates w ith response 
to oncolytic VA7 virotherapy in mouse glioma models Miika 
Mart ikainen 
11:30 – 11:40 Fisher Scientific – Efficient sample homogenisation with Precellys 
24 Isto Jänönen 
 
11:40 – 12:40 LUNCH AND EXHIBITION  
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12:40 – 14:15 ORAL SESSION VI 
Chairs: Timo Sarajärvi and Suvi Jauhiainen 
 
12:40 – 13:00 Why are photoreceptors of d ifferent insect species using a 
d ifferent set of Kv-channels? Mat t i Weckst röm 
13:00 – 13:15 Effects of human intravenous immunoglobulin on amyloid  
pathology and  neuroinflammation in a mouse model of 
Alzheimer’s d isease Lakshman Puli  
13:15 – 13:30 Genetic analysis of genes involved  in amyloid -beta degradation 
and  clearance in AD Teemu Natunen 
13:30 – 13:45 Chronic ibuprofen treatment d oes not affect the second ary 
pathology in the thalamus or improve behavioural outcome in 
MCAO rats Anu Lipsanen 
13:45 – 14:00 The effects of local VEGF gene transfer on regional lymph nodes  
Galina Dragneva 
14:00 – 14:15 Effect of spermid ine/ spermine-N 1-acetyltransferase (SSAT) on 
hematopoiesis Sini Pirnes-Karhu 
 
14:15 – 14:45 COFFEE 
 
14:45 – 15:00 Awards committee 
Best presentations 
Director of the DPMM, Best doctoral thesis  
Closing of the symposium  
 
15:00 –  Departure 
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DOCTORAL PROGRAM IN MOLECULAR MEDICINE 
WINTER SCHOOL 2011 
MARCH 15 – 16, KATINKULTA VUOKATTI 
 
PROGRAM 
 
 
POSTERS 
 
1. Evaluation of pharmacological responses by quantitative T2 fMRI Joanna 
Huttunen 
2. Implementation of migraine aura model for fMRI stud ies Artem Shat illo  
3. New insights into suscep tibility microstructure using phase spin -locking 
magnetic resonance imaging Joonas Aut io 
4. Anti-migraine medicine Naproxen inhibits ATP gated  channels and  Calcium 
oscillations in trigeminal neurons Taneli Hautaniemi  
5. Generation of patient specific induced  pluripotent stem cells Sara Paulo 
6. A non-selective Calcium channel blocker, Beprid il, decreases soluble a  and  
Calcium levels in the thalamus after MCAO in rats. Timo Sarajärv i 
7. Differential roles of MA3PKs in MAP Kinase related  Neurodegenerative 
Diseases: Development of novel MAP3Ks inhibitory compounds Maykel 
López -Rodríguez  
8. Roles and  functions of the NOS1AP adaptor protein  Xiaonan Liu 
9. Nitro-oleic acid  regulates endothelin receptor B in human endothelial cells in 
a Nrf2 dependent manner Emilia Kansanen 
10. VEGF-D stimulates VEGF-A, stanniocalcin-1 and  neuropilin-2 and  has potent 
angiogenic effects Suvi Jauhiainen 
11. Identification of novel glioma stem cell specific biomarkers and  targeting 
molecules Heini Belt  
12. VA7 infects human glioma derived  slice cultures and  primary cell cultures 
and  has only limited  replication in healthy macaque brain tissue  Janne 
Ruotsalainen 
13. The effect of ketogenic d iet on epileptiform EEG abnormalities in a mouse 
model of Alzheimer’s d isease Sofya Ziyatdinova 
14. Protein d isulphide isomerase regulates SOD1 activity and  controls 
cytochrome C-catalyzed  peroxidation in amyotrophic lateral sclerosis models  
Merja Jaronen  
15. Granulocyte colony stimulating factor reduces inflammation in a mouse 
model of ALS Eveliina Pollari 
16. NRF2 knockout mice exhibit impaired  motor function recovery and  increased  
TNF-alpha production after contusion spinal cord  injury Yuriy  Pomeshchik 
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Oral Session I 
Chairs: 
– Merja Jaronen & Sara Paulo –  
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IVIG ALLEVIATES COGN ITIVE DEFICITS AFTER GLOBAL CEREBRAL 
ISCHEMIA IN C57/BL6 MICE AND PROVIDES TIME- AND DOSE-
DEPENDENT NEUROPROTECTION 
R. Heikkinen 1 , T. Malm 1 , H. Koivisto 1 , M. Takalo 1 , A . Muona 2 , H. Tanila 1 , M. 
Koistinaho 2 , J. Koistinaho 1  
1  Department of Neurobiology, AIV Institute for Molecular Sciences, University of Eastern Finland, 2  
Medeia Therapeutics Ltd, Kuopio Finland. 
Intravenous immunoglobulin (IVIg) has trad itionally been used  to treat 
autoimmune d iseases. Recent stud ies suggest that IVIg is neuroprotective also 
against acute ischemic attack. The aim of this study was to test the neuroprotective 
potential of IVIg in a mouse model of global ischemia (GI), includ ing the most 
effective therapeutic dose and  the therapeutic time wind ow for IVIg treatment. 
Mice were treated  with a single dose of 0.1, 0.5 or 1.0 g/ kg IVIg or d iluent i.v., 1, 3 
or 6 hours after GI. A neurological test battery for motor functions, anxiety, and  
spatial learning and  memory was performed  during post -operative weeks 3 and  4. 
Histological ou tcome was analyzed  with NeuN -staining. Impairment in spatial 
learning and  reduction in survival of the CA1 hippocampal neurons were 
preveted  by a 1.0 g/ kg dose of IVIg given 1 or 3 hours after ischemia. Treatment 
with IVIG d id  not protect from motor deficits but decreased  post -ischemic anxiety 
when ad ministered  at 1h time point. A single dose of 1g/ kg IVIg given 1 or 3 
hours after GI proved  to be the most efficient in restoring spatial learning, which 
correlated  well w ith neu roprotection seen in CA1. Differential effects seen in 
motor and  navigation tasks confirm IVIg as valuable treatment for cond itions with 
hippocampal damage. 
MINOCYCLINE INHIBITS FORMATION OF INSOLUBLE TAU 
AGGREGATES IN VITRO 
Taisia Rõlova [1,2], Yuji Yoshiike [2], Miyuki Murayama [2], Jari Koistinaho [1], Akihiko Takashima 
[2] 
[1] Department of Neurobiology, University of Eastern Finland, Finland, [2] Lab for Alzheimer' s Disease, 
RIKEN Brain Science Institute, Japan 
Abnormal aggregation of microtubule-associated  protein tau contribu tes to 
neuronal dysfunction and  death that occur in neurodegenerative tauopathies, 
includ ing Alzheimer’s d isease (AD). Previous stud ies have demonstrated  that 
antibiotic minocycline can imp rove cognitive function in transgenic mouse models 
of AD and  suggested  that this d rug might have a d irect effect on tau pathology. 
The aim of the present work was to confirm the inhibitory effect of minocycline on 
tau aggregation. To avoid  any confounding factors, we first stud ied  heparin -
induced  assembly of recombinant wild -type human tau in the presence or absence 
of the d rug. Thioflavin T assay showed  that minocycline dose-dependently 
inhibited  formation of beta-sheet-structured  tau  aggregates. The find ing was 
further confirmed  by sucrose grad ient fractionation of the samples and  protein 
content analysis of each fraction. We also demonstrated  that minocycline inhibited  
tau aggregation in SHSY-5Y and  Neuro2a cell lines overexpressing P301L mutated  
human tau. Furthermore, in Neuro2a cell line, minocycline reduced  tau  
phosphorylation at Ser202 /  Ser205 resid ues, possibly by upregulating AKT and  
inhibiting GSK-3-beta activity. In conclusion, minocycline may be a promising 
drug cand idate for the treatment of tauopathies.  
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CONTRIBUTION OF MONOCYTIC CELLS DERIVED FROM 
HEMATOPOIETIC STEM CELLS OF BONE MARROW IN THE CLEARANCE 
OF AΒ OF ALZHEIMER’S DISEASE 
Ekaterina Savchenko [1], Johanna Magga [1], Tarja Malm [1], Piia Valonen [1], Anu Muona [2], 
Milla Koistinaho [2] and Jari Koistinaho [1] 
[1] Department of Neurobiology, University of Eastern Finland, Kuopio, Finland; [2] Medeia Therapeutics Ltd, 
Kuopio, Finland 
Alzheimer Disease (AD) is a progressive neurodegenerative d isorder 
characterized  by the presence of β-amyloid  (Aβ) d eposits and  neurofibrillary 
tangles in the brain. During AD pathology microglia become activated  and  
participate to some extent in the clearance of Aβ. Moreover, it has been shown that 
during the progression of AD pathology monocytes with morphological features 
of endogenous microglia are able to migrate through the blood  brain barrier (BBB) 
and  participate in the reduction of Aβ. In this study, we investigated  the ability of 
bone marrow (BM) hematopoietic stem cell (HSC) derived  monocytic cells t o 
phagocytose Aβ. HSC were isolated  from BM and  d ifferentiated  into monocytic 
cells. To study the phagocytic activity of these cells ex vivo assay was performed. 
The reduction of Aβ was analyzed  by ELISA and  immunocytochemistry . We also 
transplanted  BM HSC derived  monocytic cells into the hippocampus of 2-year-old  
APdE9 transgenic mice. Four days after the transp lantation the phagocytic activity 
and  phenotype of transp lanted  cells was determined  with immunostaining and  
confocal microscopy. The degradation of Aβ was observed  both ex vivo and  in 
vivo. These find ings suggest the role BM HSC monocytic cells as phagocytic cells 
which participate in clearance of Aβ . 
STEM CELL DERIVED HUMAN NEURAL PROGENITORS RESTORE GAIT 
IMPAIRMENTS IN A MOUSE MODEL OF CEREBRAL STROKE 
Kaisa Savolainen [1], Katja Puttonen [1], Marika Ruponen [1], Tarja Malm [1], Jonna Koponen [2], 
Seppo Ylä-Herttuala [2], Outi Hovatta [1,3], Jari Koistinaho [1], Anu Muona [1,4] 
[1] Department of Neurobiology and [2] Biotechnology and Molecular Medicine, University of Eastern Finland, 
Kuopio, [3] Karolinska Institute, Sweden, [4] Medeia Therapeutics Ltd, Kuopio, Finland 
Cerebral stroke is the third  lead ing cause of death world wide and  the current 
treatment is restricted  to tPA-therapy within 3-4 hour time window and 
rehabilitation. Human embryonic pluripotent stem cells (hESC) are able to d ivid e 
indefinitely and  d ifferentiate into any kind  of cells. Previous stud ies have shown 
that transplanted  ESC-derived  neural progenitor cells (NPCs) survive and  enhance 
functional recovery in animals with cerebral stroke. Modulation of inflammation is 
suggested  to be mostly behind  the beneficial ou tcome. In this study, we 
transplanted  200 000 hESC-derived  GFP-labeled  NPCs into the striatum of 5-
month-old  Balb/ c mice after middle cerebral artery occlusion. Already 2 wks after 
transplantation, CatWalk™ revealed  a very significant functiona l recovery in 
treated  vs. untreated  mice in several gait parameters i.e. print area (p=0.000006) 
and  d iagonal paw support (p=0.003), reaching the level of sham -operated  mice 
lasting up to 12 wks, the end  of follow -up time. Previous stud ies confirmed  the 
survival and  neuronal characteristics of the transplanted  cells along with mild  
gliosis and  accumulation of monocytic cells at the transplantation site. The results 
ind icate that transplantation of hESC can promote a d ramatic long -term motor 
recovery in mouse models of ischemic stroke. 
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A NATURALLY OCCURRING DOMINANT-NEGATIVE SPLICE VARIANT 
REGULATES THE RESPON SIVENESS OF GALPHAQ-REGULATED 
RHOGTPASE ACTIVATORS 
Lili Li, Tim Church, Soila Tossavainen, Veronika Redai, Michael Courtney  
Molecular Signalling Laboratory, Department of Neurobiology, A. I. Virtanen Institute for Molecular Sciences, 
University of Eastern Finland 
RhoGTPases have a powerful influence on cell behavior and  fate via regulation of 
transcription and  cytoskeleton. Small GTPases such as members of Rho family are 
activated  by exchange of bound  GDP for GTP, which is mediated  by guanine-
nucleotide exchange factors (GEFs). Extracellular signals activate RhoGTPases via 
G protein coupled  receptors. Gα12/ 13-regulated  GEFs are well stud ied , whereas 
not much is known about Gαq-regulated  neuronally-enriched  PKT-GEFs 
implicated  in schizophrenia and  other d iseases. We have identified  and  used  
molecular biological and  biochemical methods to characterize a novel PKT-GEF 
splice variant. This variant is expressed  in d ifferent cell types. This variant is not 
merely inactive as a Rho activator, bu t also acts as a dominant negative inhibitor of 
PKT-GEFs. Deletion analysis reveals the region sufficient for inhibition, which we 
reveal possesses an unexpected  yet strong homophilic interaction which may be 
responsible for the inhibitory action. We propose a model whereby activation of 
PKT-GEFs renders them competent to interact in trans with the inhibitory region 
of the variant. The variant may selectively target the activated  PKT-GEF 
population, thereby sharpening the response curve to activation signals to one 
with a more all-or-none character. 
ANDROGEN- AND GLUCOCORTICOID -INDUCED ACTIVATION OF 
FKBP51 LOCUS THROUGH LONG-RANGE INTERACTIONS 
Ville Paakinaho, Harri Makkonen, Tiina Jääskeläinen and Jorma J. Palvimo 
Institute of Biomedicine/Medical Biochemistry, University of Eastern Finland, Kuopio, P.O. Box 1627, FI-70211 
Kuopio, Finland  
FKBP51 (an immunophilin) is a sensitive biomarker of corticosteroid  and  
androgen responsiveness in lung and  prostate. We have elucid ated  the molecular 
mechanisms underlying the induction of FKBP51 by the glucocorticoid  receptor 
(GR) in A549 lung cancer cells and  by the androgen receptor (AR) in VCaP 
prostate cancer cells. Both cell lines show a robust accumulation of FKBP51 mRNA 
in response to exposure of their cognate steroid . ChIP scans and  enhancer activity 
analyses ind icate that activation of the FKBP51 locus by glucocorticoids and  
androgens is triggered  by the load ing of GR/ AR to enhancers at ~34 kb 5’ and  ~87 
kb 3’ from the TSS, both acting the major enhancers for AR but only the latter one 
for GR. Steroid  exposure also resulted  in significant recruitment of RNA 
polymerase II and  SWI/ SNF chromatin remodeling complexes within the locus. 
Furthermore ChIP scans show that the FKBP51 region encompassing the steroid -
regulated  enhancers is similarly bordered  by CTCF- and  cohesin-bind ing (RAD21) 
sites in both cell lines. Taken together, these results ind icate that GR/ AR are 
similarly capable of activating transcrip tion and  evoking changes in chromatin 
structure through d istant-acting enhancers by means of chromatin loops that are 
probably stabilized  by CTCF and  cohesin complexes. 
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EFFECTS OF SUMO (SMALL UBIQUITIN-RELATED MODIFIER) 
MODIFICATION ON ANDROGEN RECEPTOR  
Päivi Sutinen, Jorma Palvimo 
Institute of Biomedicine, University of Eastern Finland, Kuopio 
SUMOylation is post-translational mod ification in which small ubiquitin -like 
modifiers (SUMO-1, -2, -3) are covalently attached  to specific lysine residues of 
target proteins. One of the known SUMO targets is androgen receptor (AR). The 
AR is a ligand -regulated  transcription factor which has an important role in the 
development and  progression of prostate cancer. The AR is known to be 
SUMOylated  at two sites (K386 and  K520). In this work, w e constructed  HEK293 
cell lines that stably express wild -type (wt) or SUMOylation-deficient AR (K386 
and  K520 converted  to arginines). By using these cell lines, we compared  the 
stabilities of the wt and  the mutant AR, their abilit ies to regulate gene expression 
and  bind  to chromatin. Interestingly, the half-life of the mutant AR was shorter 
than that of the wt AR, suggesting that the SUMO modifications protect the 
receptor from degradation . qRT-PCR analyses confirmed  that certain AR target 
gene mRNAs, such as S100P mRNA and SPOCK1 mRNA, were more strongly 
expressed  in the mutant AR cells. ChIP analyses further ind icated  that the AR 
SUMOylation sites influence the kinetics of the receptor bind ing to chromatin; the 
mutant AR bound  faster and  stronger to androgen response element-containing 
chromatin sites of the latter two AR target genes. Further stud ies addressing the 
role of the SUMOylation sites in the receptor chromatin interactions on a genome -
wide scale as well as their effect on the mobility of the AR are currently under 
way. 
THE EFFECT OF SIRT1 ON ANTIOXIDANT RESPONSE ELEMENT 
MEDIATED GENE REGULATION 
Hanna Leinonen, Emilia Kansanen, Seppo Ylä-Herttuala, Anna-Liisa Levonen 
Department of Biotechnology and Molecular Medicine 
Oxidative stress is involved  in the pathogenesis of age-related  d iseases such as 
card iovascular d iseases, cancer and  neurodegenerative d isorders. Nuclear factor 
E2-related  factor 2 (Nrf2) is a transcription factor regulating the expression of 
several oxid ative stress inducible genes via bind ing to the Antioxid ant Response 
Element (ARE). Sirt1 is a class III histone deacetylase known to deacetylate many 
stress-related  transcrip tion factors lead ing either to their activation or inactivation. 
Both Nrf2 and  Sirt1 are activated  in oxidative stress, and  by a polyphenol 
resveratrol. We therefore hypothesized  that Sirt1 would  impact on Nrf2-ARE 
signalling. To test this hypothesis, Sirt1 inhibitor, nicotinamide (NAM), and  Sirt1 
overexpression were used  to assess ARE activity with reporter constructs 
containing the luciferace gene under the control of Nrf2 target gene promoter. 
NAM inhibited  both the basal and  ind ucible ARE activity, whereas Sirt1 
overexpression increased  the ARE activation by Nrf2 inducing agents. In add ition, 
NAM attenuated  Nrf2 target gene expression induced  by ARE activators. Sirt1 
also interacted  with Nrf2 in both basal as well as inducible cond itions, assessed  by 
immunoprecipitation and  western blotting. We conclude that Sirt1 positively 
regulates Nrf2 activity. 
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THE ABSENCE OF MACROPHAGE NRF2 PROMOTES ATHEROGENESIS IN 
EARLY BUT NOT IN LATE STAGES OF ATHEROSCLEROSIS 
Anna-Kaisa Ruotsalainen [1], Matias Inkala [1], Jari Lappalainen [1], Mervi Partanen [1], Suvi 
Heinonen [1], Janne Heikkilä [2], Seppo Ylä-Herttuala [1], Anna-Liisa Levonen [1] 
[1] Department of Biotechnology and Molecular Medicine, University of Eastern Finland, [2] Department of 
Oncology, Kuopio University Hospital 
Nrf2 (NF-E2-related  factor 2) is a positive regulator of many antioxid ant and  
detoxifying enzymes. Our previous stud ies ind icate that Nrf2 has 
vascu loprotective functions. However, it has been suggested  that Nrf2 promotes 
atherosclerosis by enhancing foam cell formation through upregulation of CD36 in 
macrophages. Therefore, we assessed  the effect of macrophage-specific loss of 
Nrf2 on atherogenesis. Nrf2-/ - or w ild  type (WT) bone marrow was transplanted  to 
LDLr-/ -/ ApoB100/ 100 -mice followed  by high-fat d iet (HFD) for 6 or 12 weeks. The 
cross-sectional lesion area of the aortic root and  the lesion coverage of the aorta 
was assessed . In add ition, peritoneal macrophages from WT and  Nrf2-/ - mice were 
isolated  for the assessment of CD36 expression after treatment with oxLDL or 
acLDL. CD36 induction by oxLDL and  acLDL was markedly reduced  in Nrf2-/ - 
peritoneal macrophages suggesting a role of Nrf2 in mediating the effect. The 
lesion coverage of the aortas was 4.9 ± 0.6 % and  2.2 ± 0.5 % (p< 0.01) after 6 weeks 
in Nrf2-/ - and  WT groups but no d ifference at 12 weeks. There was no significant 
d ifference between the groups in cross-sectional lesion area after 6 or 12 weeks of 
HFD. We concluded  that absence of macrophage Nrf2 promotes atherogenesis in 
early but not in advanced  stages of atherosclerosis. 
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EVALUATION OF PHARMACOLOGICAL RESPONSES BY QUANTITATIVE 
T2 FMRI 
Joanna Huttunen [1], Antti Airaksinen [1], Kimmo Lehtimäki [2], Artem Shatillo [1], Juha 
Yrjänheikki [2], Olli Gröhn [1] 
 [1] Department of Neurobiology, University of Eastern Finland, [2] Cerebricon Ltd / Charles River Labs, 
Discovery and Imaging Services, Kuopio  
Pharmacological magnetic resonance imaging (phMRI) is a novel application of 
functional MRI where the activation in the brain is induced  by a pharmacological 
agent and  measured  e.g. with blood  oxygenation level dependent (BOLD) 
contrast. The possible fluctuations (e.g. room temperature, hardware drifts) in the 
BOLD time series that are in the time scale of the pharmacological activation may 
not be filtered  easily but could  be eliminated  with the T2 maps, since the d rifts are 
presumed to be roughly similar in two sequential d atasets with d ifferent echo 
times (32 ms and  50 ms). 11 male Spraque-Dawley rats were anesthetized  with 
urethane (1.25 g/ kg, i.p .), ventilated  and  paralyzed  with pancuronium bromid e 
(0.5 mg/ kg/ h, i.v.). A bolus of nicotine (n=5, 0.25 mg/ kg, s.c.) or apomorfine (n=6, 
0.25 mg/ kg, s.c.) was ad ministered  after 500 baseline images (250 T2 maps) and  
the functional scan was continued  for 1000 images (500 T2 maps) using 7.0 T 
magnet. Nicotine caused  large positive cortical activation while smaller positive 
apomorfine responses were mainly detected  bilaterally in the lateral entorhinal 
cortices. The T2 map method  in pharmacological stud ies could  be beneficial in 
studying new pharmacological agents with small or unknown responses in the 
brain.  
IMPLEMENTATION OF MIGRAINE AURA MODEL FOR FMRI STUDIES. 
Artem Shatillo, Rashid Giniatullin, Olli Gröhn 
Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland 
The main underlying event in aura phase of migraine is cortical spread ing 
depression (CSD) which is a slow wave of neuronal and  glial depolarization that 
spreads across the cortex with a speed  of 2-7 mm/ min. The aim of this work was 
to implement a robust protocol for induction of CSD in the 9.4T magnet for 
continuous BOLD fMRI data acquisition with simultaneous local field  potentials 
(LFP) record ing in rats. Animal preparations, consisting of femoral artery and  vein 
canulation, cranial w indow opening and  insertion of LFP electrode to ipsilateral 
frontal cortex was conducted  under isoflurane anesthesia. Urethane anesthesia 
1.25 g/ kg and  muscle relaxation with ventilation (pancuronium bromide, 0.5 
mg/ kg/ h i.v.) was used  for data collection. We induced  CSD after 100 baseline 
BOLD images by applying 1M KCl solution (10μl) to intact meninges for 13 Wistar 
rats. The following imaging time was 1h (900 images). During that period , 1-5 CSD 
waves were observed  on LFP and  BOLD record ings. Based  on BOLD d ata we 
calculated  CSD properties: mean propagation speed  of 5.3 ± 1.4 mm/ min and  
duration of 129 ± 25 s. Developed  protocol allowed  us to elicit CSD with v ery 
characteristic properties in all KCl treated  animals, which makes this model usable 
for further migraine fMRI stud ies.  
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NEW INSIGHTS INTO SUSCEPTIBILITY MICROSTRUCTURE USING 
PHASE SPIN-LOCKING MAGNETIC RESONANCE IMAGING 
Joonas Autio, Lauri Lehto, Olli Gröhn 
A.I. Virtanen Institute, Department of Neurobiology, University of Eastern Finland 
Magnetic resonance imaging (MRI) can provide noninvasive measurements of 
magnetic susceptibility d ifferences in biological tissues and  phase MRI has been 
used  for clinical and  research applications. Currently used  phase MRI techniques 
are sensitive on field  inhomogeneities at all spatial length scales.  The aim of this 
study was to investigate whether a novel phase sp in -lock MRI can d istinguish 
between large and  small field  inhomogeneities.  Para- and  d iamagnetic phantoms 
were measured  using SL MRI. The results show that the SL MRI is sensitive to 
small field  inhomogeneities, whereas the larger field  inhomogeneities do not 
contribute to SL MRI contrast. The presented  method  is expected  to be valuable for 
evaluating microscopic tissue magnetic field  inhomogeneities.  
ANTI-MIGRAINE MEDICINE NAPROXEN INHIBITS ATP GATED 
CHANNELS AND CALCIUM OSCILLATIONS IN TRIGEMINAL NEURONS 
T. Hautaniemi, N. Petrenko and R. Giniatullin 
Department of Neurobiology, University of Eastern Finland 
In migraine pain, sensitized  trigeminal ganglion (TG) neurons innervating 
meninges are hyperexcitable, thus producing and  relaying nociceptive signals.  In 
the current project we tested  whether the popular anti-migraine medicine 
naproxen could  change excitability of cultured  TG neurons in fast manner via 
d irect interaction with pain transducing receptors. To this end  we used  calcium 
imaging and  patch-clamp record ings of rat trigeminal neurons activated  by the 
ATP analogue and  the TRPV1 agonist capsaicin. We found  that naproxen 
immed iately blocked  intracellu lar calcium transients activated  by the ATP 
analogue and  spared  those elicited  by capsaicin ind icating a selective sensitivity o f 
ATP-driven mechanisms. Using patch-clamp record ings we d irectly tested  the 
action of naproxen on P2X3 mediated  membrane currents. Naproxen prod uced  the 
use-dependent blocking action on ATP receptors which are known to be sensitized  
in migraine-like states (Fabbretti et al., 2006). The use-dependent mechanism of 
action presumes that the blocking action of this agent will be primarily expressed  
in most active tissues. Our data present a novel fast mechanism for the anti -
migraine action of naproxen which can  act in synergy with the COX inhibition. 
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GENERATION OF PATIENT SPECIFIC INDUCED PLURIPOTENT STEM 
CELLS 
Sara Paulo [1], Marika Ruponen [1,3], Katja Puttonen [1], Juha Rinne [4], Seppo Heinonen [5], 
Outi Hovatta [2], Jari Koistinaho [1] 
[1] Dept. of Neurobiology and [2] Dept. of Biotechnology & Molecular Medicine, A.I. Virtanen  Institute for 
Molecular Sciences, UEF, [3] School of Pharmacy, UEF, [4] University of Turku, [5] Department of Obstetrics  
and Gynaecology Kuopio University Hospital 
Induced  pluripotent stem cells (iPSCs) are stem cells derived  from somatic cells 
that resemble embryonic stem cells (ESCs). Two iPSC lines from healthy patients 
have been alread y established  and  their characterization is in underway. 
Fibroblasts cultured  from skin samples were used  to transduce with a 
polycistronic lentiviral vector carrying Oct4, Sox2, Klf4 and  c-Myc. The transd uced  
cells are grown on feeder cells and  the cultures are observed  to see that iPSCs form 
colonies with similar appearance to ESC-colonies. After 10 passages the cells are 
considered  to be bona fide iPSCs. We will perform karyotyp ing and  also DNA 
methylation assay to check the methylation status of promoters of Oct4 and  
Nanog. To confirm the iPSC’s ability to form cells of all embryonic germ layers, we 
will conduct embryoid  body and  teratoma formation assays. The pluripotency of 
the cells is also confirmed  with RT-PCR and  immunocytochemical staining of 
pluripotency markers. Our aim is to produce patient specific iPSCs that carry  
either a mutation P264L or a deletion PS-1Delta E9 in the presenilin-1 gene, both of 
which cause an inherited  form of Alzheimer’s d isease (AD). After the 
characterizations we will d ifferentiate the iPSCs into neural progenitor cells and  
fully matured  neurons to study mechanisms of AD. 
A NON-SELECTIVE CALCIUM CHANNEL BLOCKER, BEPRIDIL, 
DECREASES SOLUBLE A  AND CALCIUM LEVELS IN THE THALAMUS 
AFTER MCAO IN RATS 
T. Sarajärvi [1], A . Lipsanen [1], A . Haapasalo [1], P. Mäkinen [1], S. Peräniemi [2], H. Soininen 
[1,3], J. Jolkkonen [1], M. Hiltunen [1] 
[1] Inst. of Clinical Medicine – Neurology and [2] Dept. of Biosciences, UEF and [3] Dept. of Neurology, Kuopio 
University Hospital, Kuopio 
Alzheimer’s d isease and  cerebral ischemia share similar features in terms o f 
altered  amyloid  precursor protein processing and  -amyloid  (A ) accumulation. 
We previously observed  that A  and  calcium deposition are robustly increased  
and  that -secretase levels and  activity are altered  in ipsilateral thalamus after 
transient middle cerebral artery occlusion (MCAO) in rats. Here we investigated  
whether chronic beprid il treatment affects thalamic A  and  calcium levels and  
functional recovery after MCAO in rats. Male Wistar rats were subjected  to sham -
operation or transient MCAO. Beprid il (50 mg/ kg/ d ay, p .o.) or vehicle treatment 
was started  two days after MCAO. Cylinder and  tapered / ledged  beam walking 
tests were used  as behavioural ou tcome measures. After the follow -up, animals 
were sacrificed  for analysis of Aβ40, Aβ42, and  calcium levels in contra- and  
ipsilateral thalami. Beprid il treatment improved  forelimb use in MCAO rats in the 
cylinder test, which coincided  with decreased  calcium and  soluble A β40 and  Aβ42 
levels in the ipsilateral thalamus compared  to vehicle-treated  rats. Beprid il d id  not 
affect astrogliosis or TNF  expression. Our find ings suggest that beprid il 
decreases soluble A  and  calcium levels in the thalamus and  concomitantly 
improves sensorimotor recovery in MCAO rats. 
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DIFFERENTIAL ROLES OF MA3PKS IN MAP KINASE RELATED 
NEURODEGENERATIVE DISEASES: DEVELOPMENT OF NOVEL MAP3KS 
INHIBITORY COMPOUNDS 
Maykel López-Rodríguez, Michael Courtney 
Molecular Signalling Lab. Dept. of Neurobiology. A.I. Virtanen Institute. University of Eastern Finland. Kuopio 
No effective treatment is available for Alzheimer’s Disease, Parkinson’s Disease 
and  Cerebral Ischemia. It is therefore crucial to continue studying the pathological 
mechanisms to develop new therapies. MAPK pathways are strongly implicated 
in the pathogenesis of these d iseases and  nhibition of downstream MAPKs JN K 
and  p38 has been found  to be neuroprotective. However, the activation signals 
converge from a larger group of MAP3Ks into a smaller group of MAPKs. Thus, 
we pred ict that inhibition of MAP3Ks will resu lt in a more specific inhibitory 
effect. Within this p roject we aim to determine the d ifferential roles of MAP3Ks in 
several models of neuronal stress responses. Based  on structure-function stud ies 
we are developing a set of peptide-based  inhibitors that can be evaluated  in vivo. 
A plasmid -based  RNA interference (RNAi) library targeting all MAP3Ks has been 
created  and  is currently being valid ated  in cell lines. The effects on neuronal 
models are evaluated  using high-throughput imaging assays. We also started  
developing a set of constructs producing pep tides based  on MAP3Ks regulatory 
domains. These are being selected  based  on the capacity to inhibit MAP3Ks jud ged  
to be relevant to d isease models based  on our results from the RNAi library . 
ROLES AND FUNCTION S OF THE NOS1AP ADAPTOR PROTEIN  
Xiaonan Liu [1], Tuomo Laitinen [2], Zoher Hoosenally [3], Antti Poso [2], Michael Courtney [1] 
[1] Department of Neurobiology, University of Eastern Finland, [2] Department of Pharmaceutical Chemistry, 
University of Eastern Finland  [3] Faculty of Health and Medical Sciences, University of Surrey, UK  
Neuronal nitric oxide synthase adaptor protein (NOS1AP) is associated  with 
d iseases and  conditions includ ing sudden card iac death (SCD) and  schizophrenia, 
however their association with NOS1AP is without mechanistic exp lanation. 
Neuronal nitric oxide synthase (NOS1) is also an important factor in d isease, and  
NOS1AP is reported  to regulate NOS1. The aim of this project is to obtain further 
insights into the mechanism of action of NOS1AP. The N-terminus of NOS1AP 
contains a PTB domain, while the C-terminus includes a PDZ d omain-bind ing 
motif. We used  C-terminal deleted  forms of recombinant, purified  NOS1AP 
containing the PTB d omain and  confirmed  the C-terminal region of RasD1 could  
act as a ligand . Meanwhile, we generated  a mod el of NOS1AP-PTB using 
molecular docking method s to select a panel of candid ate ligands for evaluation in 
future bind ing experiments. The most promising ligands can then be used  to 
address biological questions and  be considered  for use in d isease models. In 
addition we used  deletion and  point mutant forms of nNOS in bind in g assays 
with N-terminally deleted  forms of NOS1AP to map the regions within the 
NOS1AP that are responsible for interaction with nNOS d isease relevance will be 
subsequently evaluated  primarily in cell culture mod els of neuronal and  card iac 
systems. 
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NITRO-OLEIC ACID REGULATES ENDOTHELIN RECEPTOR B IN HUMAN 
ENDOTHELIAL CELLS IN  A NRF2 DEPENDENT MAN NER  
Emilia Kansanen, Anna-Kaisa Ruotsalainen, Heidi Laitinen, Seppo Ylä-Herttuala, Anna-Liisa 
Levonen 
Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute for Molecular Sciences, University 
of Eastern Finland, Kuopio, Finland 
Nitro-fatty acids (NO2-FAs) are signaling mediators formed in vivo via nitric oxide 
and  nitrite dependent reactions. NO 2-FAs modulate signaling cascades via 
covalent post-translational modifications of nucleophilic amino acids in regulatory 
proteins, thus altering d ownstream signaling events, such as Keap1-Nrf2-
antioxid ant response element (ARE) regu lated  gene expression. We have recently 
explored  the effects of nitro-oleic acid  (OA-NO2) on endothelial cell transcriptome 
and  found  that one of the genes ind uced  by OA-NO2 and  very tightly regulated  by 
Nrf2 was endothelin recep tor B (ETB), which med iates the vasodilatory effects of 
endothelin-1 (ET-1). In the present study, control and  Nrf2-siRNA transfected  
human aortic and  vein end othelial cells and  mouse endothelial cells isolated  from 
either Nrf2-/ - or wt mice were treated  with vehicle or OA-NO2 and  the levels of 
endothelial receptor type A and  B were determined  by quantitative PCR. The 
result revealed  that the upregulation of ETB is tightly regulated  by Nrf2. 
Furthermore, in silico analysis of ETB gene d iscovered  four putative ARE sites in 
the ETB gene. These data suggests that Nrf2 regu lates the transcription of ETB gene, 
potentially affecting the signaling events related  to blood  pressure regulation and  
vascu lar remodeling. 
VEGF-D STIMULATES VEGF-A, STANNIOCALCIN-1 AND NEUROPILIN-2 
AND HAS POTENT ANGIOGENIC EFFECTS 
Suvi Jauhiainen, Sanna-Kaisa Häkkinen, Pyry Toivanen, Suvi Heinonen, Henna-Kaisa Jyrkkänen, 
Emilia Kansanen, Hanna Leinonen, Anna-Liisa Levonen, Seppo Ylä-Herttuala 
Department of Biotechnology and Molecular Medicine, University of Eastern Finland 
Mature form of human vascular endothelial growth factor-D (VEGF-D N C) is an 
efficient angiogenic factor under normoxic conditions but its full mechanism of 
action and  target genes have remained  unclear. We stud ied  the effects of VEGF-
D N C in human umbilical vein end othelial cells (HUVECs) and  TIME cells using 
gene array, signalling, cell culture and  in vivo gene transfer techniques. 
Concomitant with the angiogenic and  proliferative responses VEGF-D N C 
enhanced  the phosphorylation of VEGFR-2, Akt and  eNOS in HUVECs. Gene 
arrays, qRT-PCR and  western blot revealed  increases in VEGF-A, stanniocalcin-1 
(STC1) and  neuropilin (NRP)-2 expression by VEGF-D N C-stimulation, whereas 
induction with VEGF-A165, a well known activator of endothelial cells, altered  the 
expression of STC1 and  NRP1, another co-receptor for VEGFs. The effects of 
VEGF-D N C were only seen at high-serum conditions, whereas for VEGF-A165 the 
strongest response was observed  at low -serum conditions. The VEGF-D N C-
induced  upregulation of STC1 and  NRP2 was evident also in vivo in mouse hind  
limb skeletal muscle treated  with VEGF-D N C by ad enoviral gene delivery. The 
importance of NRP2 in VEGF-D N C signaling was further stud ied  with NRP2 
siRNA and  NRP antagonist which were able to block VEGF-D N C-induced  
survival of HUVECs. 
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IDENTIFICATION OF NOVEL GLIOMA STEM CELL SPECIFIC 
BIOMARKERS AND TARGETING MOLECULES 
Heini Belt [1], Outi Rautsi [1], Kirsi Vuorinen [1], Juha E. Jääskeläinen [2] and Pirjo Laakkonen [1, 
3] 
[1] AIVI, University of Eastern Finland, [2] Dept. of Neurosurgery, Kuopio University Hospital, [3] Research 
Programs Unit, University of Helsinki 
The goal of this study is to create novel tools to study and  treat malignant gliomas. 
Despite of aggressive conventional treatments and  rapid  development of novel 
cancer therapies, prognosis of patients d iagnosed  with malignant glioma remains 
poor, and  more specific therapies are needed . Gliomas, as most cancers, contain a 
subpopulation of cells that share properties with normal stem cells and  have an 
ability to initiate and  maintain the tumor. The lack of reliable glioma stem cell 
(GSC) specific markers, however, hambers the investigation of these cells. This 
study aims at identifying novel GSC specific marker s and  targeting molecules. We 
will isolate GSC from human glioma specimens with the aid  of FACS and / or 
magnetic beads, expand  them in vitro and  inject intracranially into mice. To 
identify novel GSC targeting molecu les, we will screen a phage d isp layed  pep tide 
library (CX7C peptide library on the T7Select415-1-phage) ex vivo and  in vivo to 
identify pep tide(s) that recognize(s) specific structures on the surface of GSC.  
These peptides will be used  to identify their receptor molecules = GSC biomarkers, 
and  as delivery vehicles to target GSC specific therapies to brain tumors. 
VA7 INFECTS HUMAN GLIOMA DERIVED SLICE CULTURES AND 
PRIMARY CELL CULTURES AND HAS ONLY LIMITED REPLICATION IN 
HEALTHY MACAQUE BRAIN TISSUE 
Janne Ruotsalainen [1], Miika Martikainen [1], Kirsi Vuorinen [1], Markus Vähä-Koskela[2], Juha 
Jääskeläinen [3] John Bell[2], Pirjo Laakkonen [1], Ari Hinkkanen [1] 
[1] A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland, [2] Ottawa 
Health Research Institute, Ottawa, Canada, [3] Neurosurgery, Neurocenter, Kuopio University Hospital, 
Kuopio, Finland 
Semliki Forest virus (SFV) is a non-pathogenic alphavirus, which replicates 
efficiently in a number of d ifferent cancer cell lines. In our recent stud y 
intravenously ad ministered  SFV VA7 completely eliminated  subcutaneous and  
intracranial U87 human glioma xenografts in nude mice. Here we demonstrate the 
susceptibility of a human malignant glioma biopsy d erived  tissue slice culture and  
a primary cell explant cu lture to VA7 mediated  infection and  oncolysis, and  
limited  replication in healthy Macaque brain tissue culture. Live tissue slice 
cultures and  primary cell explants were established  from a human malignant 
glioma biopsy samples and  a healthy macaque brain and  they were infected  with 
oncolytic SFV VA7 alphavirus vector. VSV Δ51-EGFP and  wtVSV-EGFP viruses 
were used  as controls in some of these infections. The cells and  spontaneously 
forming tumour spheres were infected  with VA7 virus with or without human 
IFNβ pretreatment. VA7 infected  human malignant glioma tissue slice cu ltures 
and  killed  biopsy derived  malignant glioma cell explants. The replication was 
either restricted  or delayed  in the glioma cell explant cultures after human IFN β 
pretreatment. VA7 had  only limited  and  focal replication profile in healthy 
macaque brain tissue slice culture. 
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THE EFFECT OF KETOGENIC DIET ON EPILEPTIFORM EEG 
ABNORMALITIES IN A MOUSE MODEL OF ALZHEIMER’S DISEASE. 
Sofya Z iyatdinova [1], Misha Z ilberter [2], Yuri Z ilberter [2], Tibor Harkany [2], Asla Pitkänen [1], 
Heikki Tanila [1]. 
[1] Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 
Kuopio, Finland. [2] Karolinska Institutet, Stockholm, Sweden. 
Alzheimer’s d isease (AD) is one of the priority mental health d isorders, affecting 
around  24 million people world wide. AD patients have about 8-times higher risk 
to develop unprovoked  seizures than age-matched  control population. Mice with 
amyloid  precursor protein mutation (APP) and  presenilin -1 (PS1) mutation have 
amyloid  plaques formation and  cognitive impairment. We recently showed that 
about 65% of APP/ PS1 transgenic mice have at least one unprovoked  seizure by 
the age of 5 month. Reduced  glucose utilization in AD brain cou ld  lead  to 
neuronal damage. We aim to compensate for impaired  glucose metabolism by 
complementing glucose with alternative energy substrates. We administered  
pyruvate and  beta-hydroxybutyrate enriched  d iet to female 12-13 wk old 
APP/ PS1 mice (n=9) during 5 wk, control group (n=8) received  regular mouse 
show. Video-EEG monitoring was done 24/ 7 during 1 wk before the d iet started , 
during the last 2 wk of the d iet and  during 2 wk thereafter. 3 of 17 mice included 
in the study had  seizures at baseline, 8/ 9 mice in d iet group  and  6/ 8 in control 
had  1-245 EDs per week (24±59). Number of EDs was reduced  during and  after the 
ketogenic d iet (p<0.05). Analysis of epilep tiform sp ikes is ongoing to verify the 
effect of the d iet on suppression of epileptiform activity. 
PROTEIN DISULPHIDE ISOMERASE REGULATES SOD1 ACTIVITY AND 
CONTROLS CYTOCHROME C-CATALYZED PEROXIDATION IN 
AMYOTROPHIC LATERAL SCLEROSIS MODELS 
Merja Jaronen [1], Toni Ahtoniemi [2], Jari Koistinaho [1] and Gundars Goldsteins [1] 
[1] Dept of Neurobiology, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland. [2] 
Medeia Therapeutics Ltd, Kuopio, Finland.  
Increased  mitochondrial production of ROS is a hallmark in several 
neurodegenerative d iseases, includ ing amyotrophic lateral sclerosis (ALS). Some 
forms of ALS are associated  with mutations in superoxide d ismutase -1 (SOD1) 
gene. SOD1 is present in an inactive form in the mitochondrial intermembrane 
space (IMS) where its activity is controlled  by the redox state of an intramolecular 
d isulphide bond  which is executed  by protein d isulfid e isomerase (PDI). We have 
shown that mutant SOD1 is up regulated  in the IMS and  SOD1 activity in the IMS 
increases mitochondrial ROS production by enhancing hydroperoxide production, 
resulting in augmented  cytochrome c-catalyzed  peroxidation. PDI expression 
peaks in the spinal cord  of ALS animal models at presymptomatic stage. We 
investigated  whether PDI can exercise redox control of SOD1 activity lead ing to 
increased  hydroperoxide production and  cytochrome c-catalysed  peroxid ation. 
We show that PDI catalyzes reactivation of SOD1 after inactivation by d isu lphid e 
bond  reduction. This resulted  in increased  hydroperoxide production and  
cytochrome c-catalysed  peroxidation which were inhibited  by bacitracin. 
Inhibition of PDI suppressed  also paraquat-induced  hydroperoxide production. 
These results elucid ate the possible role of PDI in controlling SOD1 activity within 
the IMS and  its impact on mitochondrial ROS production in ALS models  
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GRANULOCYTE COLONY STIMULATING FACTOR REDUCES 
INFLAMMATION IN A MOUSE MODEL OF ALS 
E. Pollari [1], K. Kanninen [1], R. Giniatullina [1], T. Ahtoniemi [2], T. Malm [1], R. Giniatullin 
[1], J. Koistinaho [1], J Magga [1] 
[1] Department of Neurobiology, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland; 
[2] Medeia Therapeutics Ltd, Kuopio, Finland. 
Amyotrophic lateral sclerosis (ALS) is a lethal motoneuron d isease without cure. 
We propose that granylocyte colony stimulating factor (G-CSF), a neuroprotective 
agent, is a promising drug candid ate for treatment of ALS. Our aim was to assess 
the G-CSF mediated  protection in the central nervous system (CNS) and  in 
inflammatory status in mouse model of ALS. Transgenic mice modelling ALS 
received  G-CSF treatment and  at d ifferent stages of the d isease an array of 
inflammatory markers in the CNS were analyzed  and  the survival was monitored . 
Neuroprotective effect of G-CSF was confirmed  in primary spinal cord  (SC) 
cultures. G-CSF treatment prolonged  the survival of the transgenic mice (from 
173±6.7 to 185±6.7 days p<0.01) and  reduced  production of proinflammatory TNF-
alpha in microglia and  monocytes. In addition, G-CSF treatment reduced  gliosis in 
the ventral horn of lumbar SC and  d iminished  ROS levels in the CNS. In primary 
SC cultures G-CSF significantly protected  against glutamate toxicity. Our data 
reveal new anti-inflammatory properties of G-CSF in a mouse model of ALS. We 
were able to demonstrate that G-CSF prolongs survival of transgenic mice and  
protects neurons in cu lture. These results valid ate beneficial properties of G -CSF 
as a neuroprotective factor for the treatment of ALS. 
NRF2 KNOCKOUT MICE EXHIBIT IMPAIRED MOTOR FUNCTION 
RECOVERY AND INCREASED TNF-ALPHA PRODUCTION AFTER 
CONTUSION SPINAL CORD INJURY 
Yuriy Pomeshchik [1], Tarja Malm [1], Katja Kanninen [1], Anna-Liisa Levonen [2], Jari Koistinaho 
[1] 
[1] Department of Neurobiology, University of Eastern Finland; [2] Department of Biotechnology and Molecular 
Medicine, University of Eastern Finland 
Spinal cord  injury (SCI) pathology is a sequence of primary injury followed  by 
second ary injury p laying a pivotal role in the outcome of p atients. Free rad ical 
damage is an important mechanism contributing to second ary d amage in SCI. NF-
E2 related  factor 2 (NRF2) is an important transcription factor responsible for 
upregulating antioxidant-responsive element (ARE)-mediated  gene expression. 
Previously we have shown activation of Nrf2-ARE pathway after SCI, but the 
effect of Nrf2-deficiency on SCI outcome is still unknown. In the present study a 
model of contusion SCI was produced  by using the Infinite Horizon Impactor after 
T10 laminectomy using Nrf-/ - mice and  their C57BL/ 6J wild -type (wt) controls. 
The mRNA level of TNF-alpha was determined  using qRT-PCR at 7 days after SCI. 
The motor function was tested  using the open -field  BMS once a week until the end  
of the stud y by two observers. Nrf2-/ - mice had  significantly lower BMS score as 
compared  with wt-injured  controls starting alread y 7 days after surgery. At that 
time-point the mRNA level of TNF-alpha was significantly upregulated  in Nrf2-/ - 
as compared  with wt-injured  injured  mice. Our results show that the Nrf2 plays 
important role on SCI pathogenesis limiting TNF-alpha production and  improving 
motor function recovery after contusion SCI. 
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UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR 
MODULATES EPILEPTOGENESIS IN MOUSE MODEL OF TEMPORAL 
LOBE EPILEPSY 
Xavier EKOLLE N and Asla Pitkänen 
Department of neuroscience, University of Eastern Finland 
Urokinase-type plasminogen activator (uPA) and  its receptor (uPAR) are induced  
by brain insu lts in animals and  humans bu t their functional role in the post -injury 
aftermath is poorly und erstood . Here we tested  a hypothesis that uPAR 
contributes to tissue remod eling after brain injury and  consequent epilept ogenesis. 
Epileptogenesis was induced  by intrahippocampal injection of kainic acid  (KA) in 
adult wild  type (Wt, n=7) and  uPAR knockout (uPAR-/ -, n=8) mice. After KA 
injection, mice were video-EEG monitored  for 30 d  (24/ 7). EEG record ings were 
analyzed  for severity of status epilepticus (SE) and  occurrence of spontaneous 
seizures. The severity of SE  during the first 48 h after KA administration was 
lower in uPAR-/ - mice compared  to Wt (p<0.01). Also, during the 30-d  follow-up, 
daily seizure frequency was lower in uPAR-/ - mice as compared  to Wt (0.7 ± 0.2 
vs. 3.0 ± 0.9, p<0.01). Histological analysis revealed  more severe degeneration in 
the ipsilateral CA1 pyramidal cells in Wt than uPAR-/ - mice (p<0.05). Also, 
degenration of ipsilateral hilar cells was more severe in Wt than uPAR-/ - mice 
(1036 ± 152 vs. 2336 ± 346 remaining, p<0.01). These data suggest that uPAR 
pred isposes neurons to post-injury degeneration augmenting epileptogenesis after 
status epilepticus. 
Acknowledgement: EU Marie Curie EST FP6, Acad emy of Finland  and  Sigrid  
Juselius Foundation  
ROLE OF AMYLOIDOGENIC APP PROCESSING IN EPILEPTOGENESIS. 
Diana Miszczuk [1,2], Heikki Tanila [1], Katarzyna Lukasiuk [2], Asla Pitkänen [1] 
[1] Department of Neurobiology, University of Eastern Finland, [2] The Nencki Institute of Experimental 
Biology, Polish Academy of Science 
Traumatic brain injury (TBI) is a major cause of epilepsy. Mechanisms of 
epileptogenesis are poorly understood  but epidemiological and  pathological 
stud ies demonstrate the association betw een TBI and  development of Alzheimer 
d iseases. To address the question if there is causality between amyloid ogenic APP 
processing and  the epilep togenesis after TBI we induced  TBI using controlled  
cortical impact model in wild  type (n=8) and  APP/ PS1 over -expressing mice 
(n=9). Sham operated  wild  type controls (n=7) and  sham injured  APP/ PS1 (n=7) 
were generated . Motor recovery was assessed  with Neuroscore 2, 7, 14 days post -
TBI. APP/ PS1 injured  mice showed significant motor deficits compared  to 
APP/ PS1 sham m ice 2 d ays (p<0.01) and  7 days (p<0.05) after TBI. Morris water -
maze was used  to evaluate spatial memory 2 weeks post TBI. There was no 
significant d ifference observed  between groups. This preliminary data suggest 
that APP/ PS1 genetic background  does not h ave strong influence on behavioral 
changes after TBI. The future aims are to analyze resu lts of fear conditioning and  
2-wk continuous vEEG monitoring. Brain tissue will be used  to evaluate level of 
mRNAs coding subunits of ion channels. We assume that in A PP/ PS1 mice TBI 
results in more robust APP accumulation and  facilitated  epileptogenesis.  
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LOSS OF GABAERGIC NEURONS IN THE RAT D ENTATE GYRUS DURING 
EPILEPTOGENESIS DEPENDS ON THE TYPE OF EPILEPTOGENIC INSULT  
Noora Huusko, Christine Römer, Asla Pitkänen 
Epilepsy Research Laboratory, Department of Neurobiology, A.I. Virtanen Institute for Molecular Science, 
University of Eastern Finland, Kuopio, Finland 
Brain insults can trigger ep ileptogenic process which after a latency phase leads to  
the epilepsy. The changes in GABAergic network in post -injury hippocampus can 
play a major role in epileptogenesis. To address a question, whether the severity of 
damage to GABAergic neurons in the rat dentate gyrus depends on the type of 
epileptogenic insult, we compared  the neuronal numbers at 6 months after status 
epilepticus (SE) and  traumatic brain injury (TBI) in adult male rats. Both SE and  
TBI rats were video-EEG monitored  to detect spontaneous seizures. TBI rats were 
also tested  in seizure threshold  test. Brains were processed  for 
immunohistochemical analysis of GABAergic neurons (NPY, PARV, CR, CCK, 
SOM). After TBI, there was a loss of all d ifferent subtypes of GABAergic neurons 
(p<0.05) in the ipsilateral and  CR-, PARV- and  CCK-immunoreactive (ir) neurons 
(p<0.05) in the contralateral dentate gyrus. These rats had  no spontaneous seizures 
but seizure threshold  was lowered . Rats with spontaneous seizures after SE (50 %) 
had  loss of NPY- and  CR-ir neurons (p<0.05) in the ipsilateral and  only NPY-ir 
neurons (p<0.05) in the contralateral dentate gyrus. Our resu lts suggest that 
epileptogenic process is not similar after TBI as compared  to SE. 
MIGRAINE MEDIATOR CGRP UP-REGULATES  PACEMAKER CHANNELS 
IN MENINGEAL NERVES AND IN ISOLATED TRIGEMINAL NEURONS: A 
NOVEL MECHANISM OF HEADACHE? 
Azat Abdullin, Nikolay Naumenko, Andrei Skorinkin, Genet Assefa, Pasi Tavi and Rashid 
Giniatullin 
Department of Neurobiology, University of Eastern Finland 
It is generally accepted  that the neuropeptide calcitonin gene related  peptide 
(CGRP) plays a central role in migraine pathology by sensitizing trigeminal 
neurons innervating meninges. But the mechanism of this sensitization is little 
understood . Since CGRP receptor induced  signaling involves cAMP in the current 
project we tested  whether this migraine mediator could  increase activity of  
cAMP-dependent pacemaker Ih channels in trigeminal sensory neurons. RT-PCR 
ind icated  expression of mRNA for several subtypes of Ih channels in rat trigeminal 
neurons. Voltage clamp record ings revealed  functional Ih channels in isolated  
trigeminal neurons which were up -regulated  after CGRP application. Using a 
novel hemiskull preparation we found  that CGRP increased  the frequency of 
spikes in trigeminal nerves in meninges from 0.84 ± 0.26 to 4.17 ± 0.62 Hz (n=10, 
P=0.0008). The specific blocker of Ih channels ZD-7288 reduced  the Ih currents in 
CGRP treated  cells and  spiking activity in d ura mater provid ing add itional 
evidence on involvement of these channels in sensitization in migraine -like states. 
Taken together our d ata suggested  a novel mechanism for migraine pain based  on 
enhanced  activity of pacemaker channels. 
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THE ROLE OF SERINE 275 IN SHAPING OF THE BINDING POCKET OF 
ATP-GATED P2X3 RECEPTOR 
Nataliia Petrenko [1], Kamil Khafizov [2] and Rashid Giniatullin [1] 
[1] Dept. Neurobiology, University of Eastern Finland; [2] Computational Structural Biology group, Max Planck 
Institute of Biophysics, Frankfurt am Main. 
ATP-activated  P2X3 receptors are expressed  in nociceptive sensory neurons and  
play important role in transmission of pain signals. One important characteristic of 
these receptors is fast and  persistent desensitization (inactivation induced  by the 
agonist ATP). Persistence of desensitization should  depend  on the rate of agonist 
d issociation from the bind ing site. However, the structure of ATP bind ing site is 
not well known. In the current work, by exp loring the structural model of P2X 
receptor, we identified  a candidate residue S275 in the ectodomain , which 
probably contributes to the closure of the agonist -bind ing pocket. Indeed , 
experimental testing of the S275A mutant using patch clamp technique not only 
revealed  a key role of the S275 in agonist bind ing but also ind icated  its crucial role 
in receptor desensitization. Thus, some full agonists of P2X3 receptor, like beta -, 
gamma-meATP became only partial agonists of the S275A mutant. Moreover, 
unlike the WT, the S275A mutant showed reduced  onset of desensitization, it was 
almost insensitive to nanomolar ATP and  desensitization was less persistent. 
Thus, our data ind icate that S275 is a key contributor to the closure of agonist -
bind ing pocket in P2X3 receptor and  its presence determines high rate and 
persistence of desensitization. 
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MICROFIBRILLAR ASSOCIATED PROTEIN 5 (MFAP5) IS LINKED WITH 
MARKERS OF OBESITY-RELATED EXTRACELLULAR MATRIX 
REMODELLING AND INFLAMMATION  
Maija Vaittinen [1], Marjukka Kolehmainen [1], Ursula Schwab [1,2], Matti Uusitupa [1,3], Leena 
Pulkkinen [1] 
[1] Institute of Public Health and Clinical Nutrition, University of Eastern Finland; [2] Institute of Clinical 
Medicine, Internal Medicine, Kuopio University Hospital, Finland; [3] Research Unit, Kuopio University 
Hospital, Finland 
We have earlier shown that the expression of MFAP5 is d own -regulated  in 
ad ipose tissue along with weight reduction in persons with metabolic syndrome 
(The Genobin study). Our aim was to exam ine if the change of MFAP5 mRNA 
expression due to weight reduction is correlated  with measures of glucose 
metabolism and  obesity. Altogether 46 obese subjects with impaired  glucose 
tolerance and  features of metabolic syndrome were rand omized  to weight 
reduction (n=28) or control group (n=18). Circulating glucose and  insulin 
concentrations and  subcutaneous AT biopsies were performed before and  after the 
intervention. The mRNA expression was stud ied  by QPCR. The mRNA expression 
of MFAP5 correlated  with BMI at baseline, and  there was a correlation between 
the change in MFAP5 mRNA expression and  the change of body fat mass. MFAP5 
mRNA expression correlated  also with fasting serum or plasma concentrations of 
ad iponectin, IL1β, insulin, leptin and  IL1Ra at baseline. In add ition, there were 
correlations between MFAP5 mRNA expression and  the expressions of PPARγ, 
ADAM12 and  CCND2 both at baseline and  after the intervention. This stud y 
demonstrates that MFAP5 is highly expressed  in AT and  is down -regulated  by 
weight reduction along with improved  insulin sensitivity. 
TCF7L2 SPLICING IS REGULATED BY WEIGHT LOSS AND DIFFERS 
BETWEEN FAT DEPOTS IN HUMANS. 
Dorota Kaminska [1, 2], Tiina Kuulasmaa [2], Tiina Sistonen [2], Sari Grönlund [3], Pirjo Käkelä 
[3] Jussi Pihlajamäki [1, 2] 
Departments of [1] Clinical Nutrition, [2] Medicine, [3] Surgery, University of Eastern Finland and Kuopio 
University Hospital 
Alternative splicing leads to transcript d iversity. A gene encoding transcription 
factor 7-like 2 (TCF7L2) is the gene most strongly linked  to type 2 d iabetes 
(T2DM). TCF7L2 has several isoforms but their role in T2DM and  obesity is not 
clear. We investigated  whether alternative splicing of TCF7L2 gene is influenced  
by substantial weight loss or between fat depots. In order to  determine this 
relationship we implemented  PCR-capillary electrophoresis method  allowing for 
efficient screening of alternatively spliced  exons.  Subcutaneous and  visceral 
ad ipose tissue samples taken during and  1 year after gastric bypass surgery were 
analyzed  from 55 ind ivid uals. Additionally, we examined  83 liver samples taken 
during the surgery. We found  alternative splicing in exon 4 and  several 3’ exons of 
TCF7L2 gene in response to weight loss, between fat depots and  between ad ipose 
tissue and  liver (p-values 0.04-1.7E-07). Interestingly, we d iscovered  correlation 
between fasting glucose and  expression of isoform lacking exons 14 and  15 of 
TCF7L2 in ad ipose tissue (r spearman=0.34, p=0.02). Finally, ad ipose tissue expression 
of this isoform was higher  in 24 obese subjects with T2DM compared  to 27 subjects 
with normal glucose tolerance (p=0.001). Our results show that alternative splicing 
of TCF7L2 gene is tissue specific, is regulated  by weight loss and  associates with 
T2DM. 
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ASSOCIATION OF INDICES OF LIVER AND ADIPOCYTE INSULIN 
RESISTANCE WITH 19 CONFIRMED SUSCEPTIBILITY LOCI FOR TYPE 2 
DIABETES IN 6,733 NON-DIABETIC FINNISH MEN. 
Jagadish Vangipurapu [1], Alena Stančáková [1], Jussi Pihlajamäki [1], Teemu Kuulasmaa [1], Tiina 
Kuulasmaa [1], Jussi Paananen [1], Johanna Kuusisto [1], Ele Ferrannini [2], Markku Laakso [1]. 
[1] Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland, 
[2] Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy  
Of the confirmed  type 2 d iabetes (T2D) susceptibility loci only a few are known to 
affect insulin sensitivity. We examined  the association of ind ices of hepatic and  
ad ipocyte insulin resistance (IR) with 19 confirmed  T2D risk loci in a large 
population-based  study. Non-d iabetic participants (n=8,460, age 57.3±7.0 years, 
BMI 26.8±3.8 kg/ m 2) from a population-based  cohort underwent an OGTT. Of 
them, 6,733 non-d iabetic men were genotyped  for single nucleotid e 
polymorphisms (SNPs) in/ near the 19 confirmed  T2D risk loci. We investigated  
hepatic IR with a new ind ex of liver IR and  used  an ad ipocyte IR index that was 
previously described . T2D risk SNPs in/ near KCNJ11 and  HHEX  were 
significantly (p<0.0013), and  those in/ near CDKN 2B, NOTCH2 and  MTN R1B were 
nominally (p<0.05), associated  with decreased  liver IR index. The Pro12 allele of 
PPARG2 was significantly associated  with a high ad ipocyte IR index and  
nominally associated  w ith high liver IR. The Pro12 allele of PPARG2 seems to 
impair insulin's antilipolytic effect, lead ing to high NEFA release in the fasting 
state and  IR. In add ition, the T2D risk alleles of KCNJ11 and  HHEX  were 
associated  with increased  hepatic insu lin sensitivity. 
PREDICTION OF MICRORNA TARGETS IN C. ELEGANS USING A SELF-
ORGANIZING MAP 
Liisa Heikkinen [1, 2], Mikko Kolehmainen [3], Garry Wong [1, 2] 
[1] Department of Neurobiology; A.I. Virtanen Institute for Molecular Sciences, [2] Department of Biosciences, 
[3] Department of Environmental Science, University of Eastern Finland, Kuopio, Finland. 
MicroRNAs are small non coding RNAs that regulate transcriptional processes via 
bind ing to the target gene mRNA. In animals, this bind ing is imperfect, wh ich 
makes the computational pred iction of animal microRNA targets a challenging 
task. The accuracy of microRNA target pred iction can be improved  with the use of 
machine learning methods. Previous work has described  methods using 
supervised  learning, but they suffer from the lack of adequate training examples, a 
common problem in microRNA target identification, which often lead s to deficient 
generalization ability. In this work, we introduce mirSOM, a microRNA target 
pred iction tool based  on clustering of short 3’ untranslated  region (UTR) 
substrings with self-organizing map (SOM). Because our method  uses 
unsupervised  learning and  a large set of verified  C. elegans 3’ UTRs, we d id  not 
need  to resort to training using a known set of targets. Our method  outperforms 
six other methods in pred icting the experimentally verified  C. elegans true and  
false microRNA targets. 
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CALCIFICATION DETECTION IN VIVO AND EX VIVO IN INJURED RAT 
BRAIN USING SWIFT 
Lauri Lehto [1], Alejandra Sierra [1], Curtis Corum [2], Djaudat Idiyatullin [2], Michael Garwood 
[2] and Olli Gröhn [1] 
[1] Department of Neurobiology, University of Eastern Finland, [2] Center for Magnetic Resonance Research, 
University of Minnesota. 
Phase imaging using conventional magnetic resonance imaging (MRI) techniques 
require post-processing of the images to remove large spatial frequency 
fluctuations. Interestingly, a novel MRI technique SWIFT also shows contrast in 
phase images without any need  for post-processing. To demonstrate the use of 
SWIFT in phase imaging, calcifications ind uced  by brain injuries were imaged . 
Two rat animal models causing brain injury and  calcifications in chronic phase 
were used : systemic pilocarpine injection ind ucin g status ep ilepticus (n=8) and  
lateral fluid  percussion traumatic brain injury (TBI, n=5). Epileptic animals were 
imaged  ex vivo and  TBI animals in vivo and  ex vivo six and  five months post -
injury, respectively. The volumes of the calcifications were estim ated  from the 
SWIFT ex vivo magnitude images and  correlated  with histology. A 
semiquantitative exp lanation for phase formation in SWIFT was developed .  Five 
pilocarpine and  5 TBI animals showed calcification formation. Calcifications were 
detected  in SWIFT phase images using their d ipole field  effect. Pooling all the 
calcifications (n=43) in all of the animals, the correlation of the calcification size 
between histology and  MRI was very good  (r=0.84). Thus, SWIFT was shown to be 
highly useful for brain calcification detection. 
SIMULTANEOUS FMRI AN D LOCAL FIELD POTENTIAL MEASUREMENTS 
OF PENTYLENETETRAZOL INDUCED EPILEPTIC SEIZURES IN 
TRAUMATIC BRAIN INJURY RATS 
Airaksinen Antti, Huttunen Joanna, Shatillo Artem, Pitkänen Asla, Gröhn Olli. 
Department of Neurobiology, UEF 
Traumatic brain injury (TBI) is a major cause of death and  d isability world wid e, 
and  can lead  to significant and  long-lasting d isabilities, such as cognitive and  
motor impairments and  post-traumatic epilepsy. In this study, we aimed  to 
characterize the origin of the seizures caused  by pentylenetetrazol (PTZ) 
administration in sham operated  and  TBI brain using functional magnetic 
resonance imaging (fMRI). Simultaneous local field  potential (LFP) and  blood  
oxygenation level depend ent (BOLD) fMRI exp eriments were performed for 14 
TBI and  6 sham operated  rats 2 months after TBI. Animals were sedated  and 
paralyzed  with mixture of medetomid ine (0.1 mg/ kg/ h) and  pancuronium 
bromide (2 mg/ kg/ h). For LFP record ings, tungsten wire electrode was implanted  
in the frontal cortex. Our preliminary resu lts showed that, the PTZ caused  bilateral 
cortical activation in BOLD signal which was also detected  as 6-8 Hz spiking in the 
LFP signal in all rats. Results are likely to increase our understand ing of the origin 
of seizures after TBI. This is an ongoing study which may provide an approach to 
study functional brain activity in abnormal brain, recovery processes after TBI and  
the progression of the seizures.  
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ROTATING FRAME SPIN LATTICE RELAXATION TIME MAPPING AND 
CINE MRI OF MYOCARDIAL INFARCTED MICE IN-VIVO AT 9.4T 
Haja-Sherief N. Musthafa [1], L. Petrov [2], G. Dragneva [1], S. Y lä-Herttuala [1], O. Gröhn [1], T. 
Liimatainen [1] 
[1] A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland ; [2]Ark 
Therapeutics Ltd., Kuopio, Finland 
Myocard ial infarction is one of the lead ing causes of d eath in the western countries 
despite improved  d iagnosis and  treatments. Locating the irreversible injury areas 
in myocard ium is one of the main approaches for d iagnosis of infraction. Spin -
lattice relaxation time in the rotating frame of reference (T1rho) was found  as a 
promising surrogate marker for cerebral ischemia, and  glioma gene therapy 
response in experimental models. In this study, T1rho was measured  before and  
after occlusion of left anterior descending coronary artery (LAD) in mice at 9.4 T 
MRI scanner. T1rho and  cine imaging was repeated  1, 3, 7 and  20 days after LAD 
surgery. For T1rho spin lock rad io frequency pu lse with five durations between 0 
and  54 ms was used . The average T1rho was calcu lated  on the infarcted  and  
loaded  myocard ium based  on cine images. The T1rho was found  to increase by 32 
% between 1st and  7th days after LAD occlusion. In our knowledge, this is the first 
time when T1rho has been measured  from mouse heart. The increase in T1rho 
after infarction reflects most likely physicochemical changes during ventricular 
remodelling. The research is continued  by resolving the reasons for increased  
T1rho by histological analyzes, and  application of T1rho for imaging of gene 
therapy after LAD occlusion. 
INTERFERON-BETA SENSITIVITY OF TUMOUR CELLS CORRELATES 
WITH RESPONSE TO ONCOLYTIC VA7 VIROTHERAPY IN MOUSE 
GLIOMA MODELS 
Miika Martikainen [1], Janne Ruotsalainen [1], Jari Heikkilä [2], Markus Vähä-Koskela [3], Ari 
Hinkkanen [1] 
[1] A. I. Virtanen Institute for Molecular Medicine, University of Eastern Finland; [2] Department of 
Biochemistry and Pharmacy, Åbo Akademi; [3] OHRI, Canada 
In our previous stud ies, intravenously administered  attenuated  Semliki Forest 
virus VA7 effectively infects and  erad icates orthotopic U87 gliomas in nude mice. 
However, in treatment of syngeneic GL261 gliomas in immunocompetent mouse 
model, VA7 (also in combination with rapamycin or cyclophosphamide) fails to 
infect the tumour cells and  shows no positive effect on survival. As virally induced  
cytokines are powerful ind ucers of antiviral response, possibly explaining the poor 
infectivity in vivo, we tested  our cell lines for their interferon -beta (IFN-beta) 
sensitivity in vitro. For this, cultured  U87 and  GL261 cells were infected  with VA7 
before and  after treating the cells with IFN -beta. Similar stud ies were done to 
GL261 cells explanted  from tumor-bearing VA7-treated  and  untreated  C57BL/ 6 
mice. IFN-beta blocks VA7 infectivity in GL261 cells in vitro. As compared  to 
GL261 cell line, U87 cell line shows lower sensitivity to IFN -beta. Our find ings 
suggest that tumour cell infectivity in vivo and  good  response to systemically 
administered  oncolytic VA7-treatment correlates to low sensitivity to vector -
induced  interferons in the targeted  cells. Strategies to safely overcome vector 
immunity are needed .  
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WHY ARE PHOTORECEPTORS OF DIFFERENT INSECT SPECIES USING A 
DIFFERENT SET OF KV-CHANNELS? 
Matti Weckström and Mikko Vähäsöyrinki 
Department of Physics and Biocenter Oulu, University of Oulu, Oulu, Finland 
Voltage-dependent potassium channels (Kv-channels) are membrane proteins that 
have essential functions in action potentials, but in the last decades it has become 
clear that they are important also in fine-tuning other, graded  potential signals in 
insect photoreceptors and  interneurons. After about two decades of experimental 
and  computational research it is possible to d raw together the d ifferent lines of 
investigation that have ar isen out of those works, with the aim of developing 
novel, mechanistic insights on the function and  importance of the Kv -channels in 
neural signalling in the insect compound eyes of several species with d ifferent 
ways-of-life. This will have general relevance in understand ing the function of the 
nervous system, includ ing that of humans. 
EFFECTS OF HUMAN INTRAVENOUS IMMUNOGLOBULIN ON AMYLOID 
PATHOLOGY AND NEUROINFLAMMATION IN A MOUSE MODEL OF 
ALZHEIMER’S DISEASE 
Lakshman Puli, Yuriy Pomeshchik, Tarja Malm, Jari Koistinaho, Heikki Tanila. 
A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. 
Human intravenous immunoglobulin (hIVIG) preparation has been hypothesized  
to confer beneficial effects in Alzheimer’s d isease (AD). Her e, we set out to 
determine the effects of hIVIG treatment on amyloid  pathology and  inflammation 
in vivo in APP/ PS1 mouse model of AD. We treated  4-month-old  female 
APP/ PS1 mice with weekly intraperitoneal injections of hIVIG (Gammagard , 
Baxter A/ G) or saline for 8 months. After the treatment the mice brains were 
rapid ly retrieved  and  processed  for rou tine histology, immunostainings and  
biochemical evaluations. hIVIG treatment d id  not cause any changes in amyloid  
plaque burden in hippocampus. Also, serum Aβ40 levels d id  not change, 
ind icating the absence of peripheral sink m echanism. Most immunohistochemical 
markers for inflammatory changes includ ing GFAP, CD68 and  Iba -1a d id  not 
change. However, we noticed  a change in hippocampal CD45 immunoreactivity in 
hIVIG treated  group. We found  no evidence for a peripheral sink or microglia 
mediated  clearance of amyloid  load  after hIVIG treatment. However, hIVIG 
suppressed  subset of microglial cells positive for CD45 antigen. These 
immunomodulatory effects of hIVIG may account for its beneficial effect in AD 
patients. 
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GENETIC ANALYSIS OF GENES INVOLVED IN AMYLOID-BETA 
DEGRADATION AND CLEARANCE IN AD  
Teemu Natunen, Seppo Helisalmi, Saila Vepsäläinen, Timo Sarajärvi, Leila Antikainen, Petra 
Mäkinen, Sanna-Kaisa Herukka, Anne Maria Koivisto, Annakaisa Haapasalo, Hilkka Soininen, and 
Mikko Hiltunen*  
Institute of Clinical Medicine – Neurology, University of Eastern Finland and Department of Neurology, Kuopio 
University Hospital, P.O.Box 1627, FIN -70211 Kuopio, Finland 
Accumulation of amyloid  β-peptide (Aβ) in the brain of Alzheimer's d isease (AD) 
patients has been postulated  to reflect defects in Aβ degradation or clearance. 
Here, we have selected  12 genes involved  in Aβ degrad ation or clearance and  
elucidated  their genetic role in AD among Finnish case-control cohort consisting of 
~1300 AD patients and  controls in total. Association analysis of the liver X receptor 
α (NR1H3) gene SNPs showed a protective effect for C allele carriers of rs7120118 
(p=0.014; OR=0.70, 95% CI 0.53-0.93). Consistent with this, the phospho-tau levels 
were significantly decreased  in the cerebrospinal fluid  (CSF) of AD patients 
carrying the C allele. Moreover, a significant decrease in the age of onset was 
observed  in AD patients carrying the A allele of rs723744 and  the C allele of 
rs3794884 in transthyretin (TTR) gene. The phospho-tau levels in CSF were again 
increased  among AD patients carrying the G allele of rs1080093 in TTR gene. 
These results suggest that genetic alterations in NR1H3 and  TTR may play a role 
in AD pathogenesis. 
CHRONIC IBUPROFEN TREATMENT DOES NOT AFFECT THE 
SECONDARY PATHOLOGY IN THE THALAMUS OR IMPROVE 
BEHAVIOURAL OUTCOME IN MCAO RATS 
Anu Lipsanen, Mikko Hiltunen and Jukka Jolkkonen 
Department of Clinical Medicine – Neurology, University of Eastern Finland, Kuopio, Finland  
Anti-inflammatory drug ibuprofen decreases the β-amyloid  (Aβ) deposition and  
associated  inflammation in transgenic Alzheimer d isease mice. Based  on this, we 
stud ied  whether ibuprofen could  modulate the secondary pathology described  in 
the thalamus of middle cerebral artery occlusion (MCAO) rats. Our hypothesis 
was that ibuprofen could  decrease inflammatory reaction and  A β load  in the 
thalamus of MCAO rats, which reflects in behavioral outcome. Forty Wistar rats 
were subjected  to sham-operation or transient occlusion of the right MCA (120 
min). Ibuprofen (40 mg/ kg/ day, per os)/ vehicle was ad ministrated  for 27 d ays 
beginning the treatment on post-operative day 2. Sensorimotor impairment was 
assessed  using the limb-placing, tapered / ledged  beam -walking and  cylinder tests 
during the follow -up. The rats were perfused  for histology on postoperative day 
29. H istological data showed  that ibuprofen d id  not affect Aβ or calcium load  in 
the thalamus of MCAO rats. In add ition, behavioral tests d id  not show significant 
d ifference between vehicle- and  ibuprofen-treated  MCAO rats. The present d ata 
do not support the idea that ibuprofen redu ces the secondary Aβ/ calcium 
pathology in the thalamus or associated  sensorimotor impairment following 
cerebral ischemia.  
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THE EFFECTS OF LOCAL VEGF GENE TRANSFER ON REGIONAL LYMPH 
NODES 
Galina Dragneva, Ivana Kholová, Laura Alasaarela, Felisitas Yongabi, Seppo Ylä-Herttuala. 
Dept. of Biotechnology and Molecular Medicine, University of Eastern Finland  
In this study we aim to outline the histopathological and  molecular biological 
effects of d ifferent VEGFs on regional lymph nodes after local gene transfer into 
mouse skeletal muscles. Intramuscular injections of AdhVEGF-A, AdhVEGF-D 
(proteolytically processed  form), AdhVEGF-C or AdLacZ were performed on 
ApoB48-LDLR-/ - mouse skeletal muscles. We carried  out detailed  morphological 
analysis to determine any tissue changes in the regional lymph nodes by means of 
hematoxylin-eosin, special stains and  immunohistochemistry. The transgene 
expression was assessed  by qRT-PCR. The transgene protein levels were 
determined  by ELISA. Histopathological results in regional lymph nodes 
demonstrated  sinus d ilation, activated  lymphatic follicles and  paracortical 
hyperplasia as well as generation of angiogenesis and  lymphangiogenesis. The 
highest level of angiogenesis was recorded  after AdhVEGF-D gene transfer, while 
the highest level of lymphangiogenesis was detected  after AdhVEGF-C gene 
transfer. All the transgenes were detected  both on mRNA and  protein level on D7. 
The evaluation of the transgene expression in d ifferent non -target organs such as 
lymphoid  tissue may prove important in assessing the safety pattern of any gene 
transfer vector. 
EFFECT OF SPERMIDINE/SPERMINE-N 1-ACETYLTRANSFERASE (SSAT) 
ON HEMATOPOIESIS 
Sini Pirnes-Karhu [1], Sisko Juutinen [1], Petri Mäkinen [1], Sohvi Hörkkö [2], Esa Jantunen [3], 
Pentti Mäntymaa [4], Leena Alhonen [1], Anne Uimari [1] 
[1] Department of Biotechnology and Molecular Medicine, University of Eastern Finland, [2] Department of 
Microbiology, University of Oulu, [3] Institute of Clinical Medicine, Internal Medicine, Kuopio University 
Hospital, [4] Eastern Finland Laboratory Centre 
Polyamines are small cationic molecules essential for many cellular processes, 
includ ing cell growth and  d ifferentiation. The mice over -expressing 
spermid ine/ spermine-N 1-acetyltransferase (SSAT), a catabolic regulator of 
polyamines, have several phenotypic and  metabolic changes when compared  with 
their non-transgenic littermates. The hematopoietic features of these mice were 
examined  by histology, blood  count and  FACS analyses, bone marrow 
transplantation and  by treating mice with inhibitors of NF-κB and  DNA/ histone 
modifying enzymes. The SSAT over-expressing mice exhibited  enlarged  secondary 
lymphoid  tissues and  elevated  amount of leukocytes in blood  and  bone marrow. 
In add ition, the relative proportions of leukocyte subpopulations were altered  in 
blood , sp leen and  bone marrow. The changes in leukocyte populations seemed to 
originate from SSAT over-expression in the hematopoietic stem and / or progenitor 
cells, as demonstrated  by the bone marrow transp lantation . Also human leukemia 
samples showed  altered  p olyamine metabolism. This study will give new 
information about the role of polyamines and  their metabolism in cell proliferation 
and  d ifferentiation processes. 
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